| AEPCX | NIQVX | AEPCX / NIQVX | |
| Total Expense Ratio | 1.58 | 1.22 | 130% |
| Annual Report Gross Expense Ratio | 1.58 | 1.22 | 130% |
| Fund Existence | 25 years | 14 years | - |
| Gain YTD | 5.487 | 6.114 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 137B | 1.02B | 13,431% |
| Annual Yield % from dividends | 2.13 | 1.01 | 211% |
| Returns for 1 year | 4.80 | 1.94 | 248% |
| Returns for 3 years | 24.57 | 33.55 | 73% |
| Returns for 5 years | -4.80 | -4.82 | 100% |
| Returns for 10 years | 38.48 | 50.02 | 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSFBX | 27.60 | 0.36 | +1.32% |
| Morgan Stanley Inst Global Franchise A | |||
| WGROX | 83.03 | 0.76 | +0.92% |
| Wasatch Core Growth | |||
| PBSYX | 20.40 | -0.18 | -0.87% |
| Polen 5Perspectives Small Growth Y | |||
| JMNSX | 15.17 | -0.20 | -1.30% |
| JPMorgan Research Market Neutral I | |||
| PASTX | 67.83 | -1.16 | -1.68% |
| T. Rowe Price Science & Tech Adv | |||